TS Financial Group (TSFG)’s ANI Pharmaceuticals ANIP Stock Holding History

TS Financial Group (TSFG)’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-30	Closed	-$2K	–	873
2023 Q3	$2K	Hold	30	–	–	﹤0.01%	799
2023 Q2	$2K	Hold	30	–	–	﹤0.01%	808
2023 Q1	$1K	Hold	30	–	–	﹤0.01%	859
2022 Q4	$1K	Hold	30	–	–	﹤0.01%	876
2022 Q3	$1K	Hold	30	–	–	﹤0.01%	851
2022 Q2	$1K	Hold	30	–	–	﹤0.01%	867
2022 Q1	$1K	Hold	30	–	–	﹤0.01%	832
2021 Q4	$1K	Hold	30	–	–	﹤0.01%	798
2021 Q3	$1K	Hold	30	–	–	﹤0.01%	781
2021 Q2	$1K	Hold	30	–	–	﹤0.01%	780
2021 Q1	$1K	Hold	30	–	–	﹤0.01%	703
2020 Q4	$1K	Hold	30	–	–	﹤0.01%	799
2020 Q3	$1K	Hold	30	–	–	﹤0.01%	717
2020 Q2	$1K	Hold	30	–	–	﹤0.01%	700
2020 Q1	$1K	Hold	30	–	–	﹤0.01%	647
2019 Q4	$2K	Hold	30	–	–	﹤0.01%	596
2019 Q3	$2K	Hold	30	–	–	﹤0.01%	619
2019 Q2	$2K	Hold	30	–	–	﹤0.01%	596
2019 Q1	$2K	Buy	+30	New	+$1.76K	﹤0.01%	569

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TS Financial Group (TSFG)'s ANIP Position: Q4 2023 in Review

TS Financial Group (TSFG) sold out of ANI Pharmaceuticals (ANIP) in Q4 2023, closing a stake of 30 shares — an estimated $2K sold.

TS Financial Group (TSFG) first reported a position in ANIP in Q1 2019 and held it in 19 quarters. The position peaked at $2K in Q3 2023. 181 funds tracked by Wall St. Rank hold ANIP as of Q4 2023.

TS Financial Group (TSFG) reported no remaining ANI Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
TS Financial Group (TSFG) sold 30 ANI Pharmaceuticals shares in Q4 2023, an estimated $2K.
TS Financial Group (TSFG) first reported a position in ANI Pharmaceuticals in Q1 2019 and held it in 19 quarters.
TS Financial Group (TSFG)'s ANI Pharmaceuticals position peaked at $2K in Q3 2023.
181 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2023.

Based on TS Financial Group (TSFG)'s 13F filing for Q4 2023, filed 24 Jan 2024.